These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 575396

  • 1. Mode of antagonistic action of levallorphan in morphine-dependent rats and assessment of physical dependence liability.
    Tagashira E, Izumi T, Yanaura S.
    Jpn J Pharmacol; 1979 Aug; 29(4):623-30. PubMed ID: 575396
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [A study on drug dependence using fast acting drugs].
    Yanaura S, Tagashire E, Izumi T.
    Nihon Yakurigaku Zasshi; 1975 May; 71(4):329-37. PubMed ID: 1237448
    [Abstract] [Full Text] [Related]

  • 5. Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats.
    Bläsig J, Herz A, Reinhold K, Zieglgänsberger S.
    Psychopharmacologia; 1973 Oct 23; 33(1):19-38. PubMed ID: 4797644
    [No Abstract] [Full Text] [Related]

  • 6. Sites of action of morphine involved in the development of physical dependence in rats. I. Comparison of precipitated morphine withdrawal after intraperitoneal and intraventricular injection of morphine antagonists.
    Laschka E, Herz A, Bläsig J.
    Psychopharmacologia; 1976 Mar 16; 46(2):133-9. PubMed ID: 986051
    [Abstract] [Full Text] [Related]

  • 7. The antagonizing effect of aspartic acid on morphine withdrawal and levallorphan-precipitated abstinence syndrome signs and on associated changes in brain levels of free amino acids in the rat.
    Koyuncuoğlu H, Güngör M, Eroğlu L, Sağduyu H.
    Psychopharmacology (Berl); 1979 Mar 29; 62(1):89-95. PubMed ID: 108753
    [Abstract] [Full Text] [Related]

  • 8. Aspects of abstinence after morphine ingestion.
    Rönnbäck L, Eriksson PS, Zeuchner J, Rosengren L, Wronski A.
    Pharmacol Biochem Behav; 1987 Sep 29; 28(1):87-93. PubMed ID: 3659110
    [Abstract] [Full Text] [Related]

  • 9. Proceedings: Site of action of morphine in the development of physical dependence in rats.
    Laschka E, Teschemacher H, Mehraein D, Herz A.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 Sep 29; 282(Suppl):suppl 282:R54. PubMed ID: 4276597
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Physical dependence on morphine, phenobarbital and diazepam in rats by drug-admixed food ingestion.
    Yanaura S, Tagashira E, Suzuki T.
    Jpn J Pharmacol; 1975 Aug 29; 25(4):453-63. PubMed ID: 1239608
    [Abstract] [Full Text] [Related]

  • 12. [Physical dependence liability test of ifenprodil in rats (author's transl)].
    Yanaura S, Tagashira E, Nagase T, Izumi T.
    Nihon Yakurigaku Zasshi; 1978 Mar 29; 74(2):303-16. PubMed ID: 566249
    [Abstract] [Full Text] [Related]

  • 13. [Problems in quantification of provoked morphine withdrawal in rats].
    Herz A, Bläsig J.
    Arzneimittelforschung; 1974 Jul 29; 24(7):1012-4. PubMed ID: 4408092
    [No Abstract] [Full Text] [Related]

  • 14. Changes in self-stimulation response during chronic morphine treatment and after withdrawal of morphine in rats.
    Kamei C.
    Jpn J Pharmacol; 1994 Sep 29; 66(1):163-5. PubMed ID: 7861664
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of cholinergic and anticholinergic drugs and a partial cholinergic agonist on the development and expression of physical dependence on morphine in rat.
    Frederickson RC, Pinsky C.
    J Pharmacol Exp Ther; 1975 Apr 29; 193(1):44-55. PubMed ID: 1169318
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sites of action of morphine involved in the development of physical dependence in rats. II. Morphine withdrawal precipitated by application of morphine antagonists into restricted parts of the ventricular system and by microinjection into various brain areas.
    Laschka E, Teschemacher H, Mehraein P, Herz A.
    Psychopharmacologia; 1976 Mar 16; 46(2):141-7. PubMed ID: 986052
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.